3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other
1
Conditions
Breast Neoplasms
1931
Neoplasms
1385
Carcinoma, Non-Small-Cell Lung
1324
Prostatic Neoplasms
1070
Multiple Myeloma
855
Leukemia, Myeloid, Acute
759
Neoplasm Metastasis
691
Colorectal Neoplasms
676
Melanoma
666
Lung Neoplasms
665
Lymphoma
655
Leukemia
591
Lymphoma, Non-Hodgkin
587
Leukemia, Lymphocytic, Chronic, B-Cell
529
Ovarian Neoplasms
517
Pancreatic Neoplasms
493
Precursor Cell Lymphoblastic Leukemia-Lymphoma
471
Recurrence
466
Myelodysplastic Syndromes
421
Lymphoma, Follicular
407
Head and Neck Neoplasms
401
Glioblastoma
376
Carcinoma, Renal Cell
375
Lymphoma, Large B-Cell, Diffuse
372
Brain Neoplasms
370
Hodgkin Disease
352
Carcinoma, Hepatocellular
324
Squamous Cell Carcinoma of Head and Neck
323
Lymphoma, Mantle-Cell
302
Sarcoma
281
Interventions
Therapeutics
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Has results
×
Nutrition Disorders
×
Clear all
NCT03443635
2022-04-29
CHOP
Tulane University
Phase 1/2
Completed
7,192 enrolled
7 charts